To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.

Bill: 116-hr-2855
Sponsor: full_name: Rep. King, Steve [R-IA-4]
Introduced: 2019-05-20
Subjects: Private Legislation
Latest action: action_date: 2019-05-21
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2019-05-20
action_desc: Introduced in House
text: <p>This bill provides for approval of the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides.</p>

tv_txt: V 116th CONGRESS 1st Session H. R. 2855 IN THE HOUSE OF REPRESENTATIVES May 20, 2019 Mr. King of Iowa introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.

1. Deemed approval of application for compassionate use of the gene therapy antisense oligonucleotides Notwithstanding the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 301 et seq.) or any other provision of law, the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides is deemed to be approved.